C1q and Tumor Necrosis Factor Related Protein 5 (C1QTNF5) (N-Term) Peptide

Details for Product No. ABIN1004122, Supplier: Log in to see
Protein Name
  • C1QTNF5
  • wu:fb02c10
  • wu:fb02f05
  • zgc:112378
  • CTRP5
  • Ctrp5
  • C1q and tumor necrosis factor related protein 5
  • C1QTNF5
  • c1qtnf5
  • C1qtnf5
Protein Region
Western Blotting (WB)
Log in to see
Supplier Product No.
Log in to see
Blocked Antibody anti-C1q/TNF-alpha Related Protein 5 (Adipokine-Related) (N-Term) antibody (ABIN1001954)
Characteristics 15 amino acids near the amino terminus of human CTRP5.
Application Notes CTRP5 peptide is used for blocking the activity of CTRP5 antibody . It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37ºC.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer Supplied in PBS pH 7.2 (10 mM NaH₂PO₄, 10 mM Na₂HPO₄, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. The peptide solution should be gently mixed before use.
Storage -20 °C
Storage Comment Store at -20°C, stable for one year.
Expiry Date 12 months
Product cited in: Song, Ouyang, Bao: "The activation of Akt/PKB signaling pathway and cell survival." in: Journal of cellular and molecular medicine, Vol. 9, Issue 1, pp. 59-71, 2005 (PubMed).

Bellacosa, Testa, Staal, Tsichlis: "A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region." in: Science (New York, N.Y.), Vol. 254, Issue 5029, pp. 274-7, 1991 (PubMed).

Background publications Alessi, Andjelkovic, Caudwell, Cron, Morrice, Cohen, Hemmings: "Mechanism of activation of protein kinase B by insulin and IGF-1." in: The EMBO journal, Vol. 15, Issue 23, pp. 6541-51, 1997 (PubMed).